Intra Cellular Therapies Inc Asset Turnover Ratio (ITCI), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Intra cellular Therapies Inc   (NASDAQ: ITCI)
 

Intra Cellular Therapies Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2024, Intra Cellular Therapies Inc 's asset turnover ratio sequentially decreased to 0.58 in the fourth quarter (Dec 31 2024), this is lower than usual.

Within sector 115 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2024 compared to the preceding quarter from 2692 to 2884.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ITCI Asset Turnover Ratio (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Asset Change 88.7 % 85.86 % 86.48 % 3.83 % -3.29 %
Y / Y Revenue Change 50.81 % 39 % 45.67 % 52 % 50.34 %
Asset Turnover Ratio (TTM) 0.58 0.6 0.65 0.72 0.66
ITCI's Total Ranking # 2884 # 2692 # 901 # 571 # 2322
Seq. Asset Change 3.29 % 0.31 % 77.53 % 2.59 % 1.74 %
Seq. Revenue Change 13.6 % 8.67 % 11.41 % 9.66 % 4.7 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 116
Healthcare Sector # 397
Overall Market # 2884

Asset Turnover Ratio Statistics
High Average Low
7.21 4.78 3.73
(Dec 31 2017)   (Sep 30 2020)




ITCI Company Profile • Back to ITCI Efficiency Comparisons • Compare ITCI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Assets at quarter ending Dec 31 2024
Talkspace Inc   1.36 $ 186.836  Millions$ 137.243  Millions
Sanuwave Health Inc   1.36 $ 32.634  Millions$ 24.075  Millions
Bioaffinity Technologies Inc   1.35 $ 9.362  Millions$ 6.943  Millions
Viemed Healthcare Inc   1.35 $ 224.257  Millions$ 166.354  Millions
Rigel Pharmaceuticals Inc  1.28 $ 179.278  Millions$ 139.581  Millions
Docgo Inc   1.28 $ 616.555  Millions$ 482.089  Millions
Infusystem Holdings Inc  1.28 $ 134.861  Millions$ 105.574  Millions
Electrocore Inc   1.25 $ 24.397  Millions$ 19.440  Millions
Ardent Health Inc   1.25 $ 5,966.072  Millions$ 4,774.091  Millions
Nephros Inc   1.24 $ 13.723  Millions$ 11.028  Millions
Koru Medical Systems Inc   1.23 $ 33.646  Millions$ 27.353  Millions
Henry Schein Inc   1.23 $ 12,673.000  Millions$ 10,304.750  Millions
Xtant Medical Holdings Inc   1.23 $ 117.216  Millions$ 95.557  Millions
Aveanna Healthcare Holdings Inc   1.22 $ 2,024.506  Millions$ 1,653.744  Millions
Warby Parker Inc   1.22 $ 770.834  Millions$ 631.395  Millions
Qhslab Inc   1.22 $ 2.132  Millions$ 1.748  Millions
Hca Healthcare Inc   1.21 $ 70,603.000  Millions$ 58,328.250  Millions
Evofem Biosciences Inc   1.20 $ 19.363  Millions$ 16.125  Millions
Indivior Pharmaceuticals Inc   1.19 $ 2,078.000  Millions$ 1,745.500  Millions
Mettler toledo International Inc   1.18 $ 3,872.361  Millions$ 3,273.027  Millions
Electromed Inc   1.18 $ 59.626  Millions$ 50.571  Millions
Nuwellis Inc   1.18 $ 8.662  Millions$ 7.361  Millions
Exagen Inc   1.17 $ 55.112  Millions$ 47.102  Millions
Vaso Corporation  1.16 $ 86.767  Millions$ 74.597  Millions
Idexx Laboratories Inc  1.16 $ 3,896.927  Millions$ 3,353.148  Millions
Evolus Inc   1.16 $ 266.274  Millions$ 230.531  Millions
Trisalus Life Sciences Inc   1.15 $ 29.328  Millions$ 25.442  Millions
Dynatronics Corporation  1.15 $ 29.933  Millions$ 26.134  Millions
Sunshine Biopharma Inc   1.15 $ 34.874  Millions$ 30.454  Millions
Neuroone Medical Technologies Corp  1.14 $ 6.455  Millions$ 5.656  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.